TrialDrugs & aging2020

Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet.

Sender Herschorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.